2-(Furan-2-yl)-6-nitroquinoline-4-carboxylic acid, 95%, 250mg

Dibutyl 2-methylenesuccinate, (stabilized with HQ), 98% (stabilized with HQ), 25g

2-Amino-5-ethylphenol, 95.0%, 100mg

2-Ethyl-1-hexene>95.0%(GC)25mL

Tolnaftate>97.0%(HPLC)(N)5g

Xylene (isomers), 1 l, glass

tert-Butyl ((2S,3R)-2-methylpiperidin-3-yl)carbamate, 95%, 100mg

Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enecarboxylate, 95.0%, 250mg

Buffer solution pH 8.00 ±0.02 (20 °C), ROTI®Calipure ready to use, 250 ml

N-{2-[(oxiran-2-yl)methoxy]phenyl}acetamide, 95.0%, 500mg

Tetrahydropyran-4-methanol>97.0%(GC)5g

bScope BS.1152-PLPHi for phase contrast. Biocular with HWF 10x/20 mm eyepieces and Fivefold revolver E-plan Phase IOS 10/20/S40 S100x

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(thiophen-2-yl)propanoic acid, 95.0%, 5g